Whalesbook
Apollo Hospitals Enterprise shares reached a 52-week peak of ₹8,388 on the NSE on Thursday, fueled by the company's latest financial results for the fourth quarter of fiscal year 2025-26.
Strong Fourth Quarter Performance
The hospital group announced a consolidated revenue from operations of ₹6,606 crore, marking an 18.10% increase from ₹5,592 crore in the same period last year. Consolidated profit after tax (PAT) rose significantly by 35.60% to ₹529 crore, up from ₹390 crore year-on-year. Earnings before interest, tax, depreciation, and amortization (Ebitda) also showed healthy growth, increasing by 31% to ₹1,010 crore.
Dividend and Strategic Restructuring
In addition to its financial results, the Apollo Hospitals board proposed a final dividend of ₹10 per equity share for FY2025-26, pending shareholder approval. The record date for this dividend is scheduled for August 14, 2026. The company also revealed that its board has approved the merger of its wholly-owned subsidiary, Apollo Hospitals North Limited, with the parent company. In a separate strategic move, Apollo Health and Lifestyle Limited (AHLL) will sell its stakes in Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited for approximately ₹1,550 crore. This transaction is intended to establish a leading integrated maternity and fertility care platform in India.